loadpatents
name:-0.044627904891968
name:-0.034966945648193
name:-0.0033841133117676
Harley; Calvin B. Patent Filings

Harley; Calvin B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harley; Calvin B..The latest application filed is for "method for identification of sensitivity of a patient to telomerase inhibition therapy".

Company Profile
3.34.30
  • Harley; Calvin B. - Murphys CA
  • Harley; Calvin B. - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20210269861 - Harley; Calvin B. ;   et al.
2021-09-02
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20190382829 - Harley; Calvin B. ;   et al.
2019-12-19
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 10,196,677 - Harley , et al. Fe
2019-02-05
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20170298421 - Harley; Calvin B. ;   et al.
2017-10-19
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 9,617,583 - Harley , et al. April 11, 2
2017-04-11
Method for Eliciting an Immune Response to Human Telomerase Reverse Transcriptase
App 20160263203 - CECH; THOMAS R. ;   et al.
2016-09-15
Compositions and methods for skin conditioning
Grant 9,248,088 - Harley , et al. February 2, 2
2016-02-02
Method for Eliciting an Immune Response to Human Telomerase Reverse Transcriptase
App 20150250863 - Cech; Thomas R. ;   et al.
2015-09-10
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20150152488 - Harley; Calvin B. ;   et al.
2015-06-04
Method for identification of sensitivity of a patient to telomerase inhibition therapy
Grant 8,877,723 - Harley , et al. November 4, 2
2014-11-04
Method for eliciting an immune response to human telomerase reverse transcriptase
Grant 8,709,995 - Cech , et al. April 29, 2
2014-04-29
Compositions and methods for increasing telomerase activity
Grant 8,481,721 - Harley , et al. July 9, 2
2013-07-09
Human telomerase catalytic subunit
Grant 8,236,774 - Cech , et al. August 7, 2
2012-08-07
Kit for detection of telomerase reverse transcriptase nucleic acids
Grant 8,222,392 - Cech , et al. July 17, 2
2012-07-17
Assay for Telomerase Activity Using Microfluidic Device
App 20120070842 - Harley; Calvin B. ;   et al.
2012-03-22
Human Telomerase Catalytic Subunit
App 20110318832 - Cech; Thomas R. ;   et al.
2011-12-29
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
App 20110263685 - Harley; Calvin B. ;   et al.
2011-10-27
Compositions and Methods for Increasing Telomerase Activity
App 20100292197 - Harley; Calvin B. ;   et al.
2010-11-18
Antibody to telomerase reverse transcriptive
Grant 7,750,121 - Cech , et al. July 6, 2
2010-07-06
Human telomerase reverse transcriptase polypeptides
Grant 7,622,549 - Cech , et al. November 24, 2
2009-11-24
Kit for detection of telomerase reverse transcriptase nucleic acids
App 20090269739 - Cech; Thomas R. ;   et al.
2009-10-29
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
Grant 7,585,622 - Cech , et al. September 8, 2
2009-09-08
Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
Grant 7,560,437 - Cech , et al. July 14, 2
2009-07-14
Hair Follicle Pharmacodynamic Assay for Telomerase Activity
App 20090142770 - Go; Ning F. ;   et al.
2009-06-04
Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
Grant 7,517,971 - Cech , et al. April 14, 2
2009-04-14
Immunogenic composition
App 20080279871 - Cech; Thomas R. ;   et al.
2008-11-13
Treating cancer using a telomerase vaccine
Grant 7,413,864 - Cech , et al. August 19, 2
2008-08-19
Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
Grant 7,297,488 - Cech , et al. November 20, 2
2007-11-20
Antibody to telomerase reverse transcriptase
Grant 7,285,639 - Cech , et al. October 23, 2
2007-10-23
Nucleic acids encoding human telomerase reverse transcriptase and related homologs
Grant 7,262,288 - Cech , et al. August 28, 2
2007-08-28
Treatment for wounds
Grant 7,262,174 - Jiang , et al. August 28, 2
2007-08-28
Compositions and methods for skin conditioning
App 20070154435 - Harley; Calvin B.
2007-07-05
Mammalian cells that have increased proliferative capacity
Grant 7,195,911 - Cech , et al. March 27, 2
2007-03-27
Enhancing cell migration by increasing telomerase activity
App 20060239974 - Jiang; Xu-Rong ;   et al.
2006-10-26
Telomerase
Grant 7,056,513 - Cech , et al. June 6, 2
2006-06-06
Methods for detecting nucleic acids encoding human telomerase reverse transcriptase
Grant 7,005,262 - Cech , et al. February 28, 2
2006-02-28
Human telomerase catalytic subunit
App 20060040307 - Cech; Thomas R. ;   et al.
2006-02-23
Genes for human telomerase reverse transcriptase and telomerase variants
Grant 6,927,285 - Cech , et al. August 9, 2
2005-08-09
Telomerase
Grant 6,921,664 - Cech , et al. July 26, 2
2005-07-26
Treating cancer using antisense oligonucleotides against telomerase reverse transcriptase
App 20050070492 - Cech, Thomas R. ;   et al.
2005-03-31
Vaccine containing the catalytic subunit of telomerase for treating cancer
App 20050013825 - Cech, Thomas R. ;   et al.
2005-01-20
Treating cancer using a telomerase vaccine
App 20040247613 - Cech, Thomas R. ;   et al.
2004-12-09
Vector encoding inactivated telomerase for treating cancer
App 20040242529 - Cech, Thomas R. ;   et al.
2004-12-02
Treatment for wounds
App 20040147465 - Jiang, Xu-Rong ;   et al.
2004-07-29
Methods of screening for compounds that derepress or increase telomerase activity
App 20030190638 - West, Michael D. ;   et al.
2003-10-09
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
Grant 6,627,619 - Cech , et al. September 30, 2
2003-09-30
Cells immortalized with telomerase reverse transcriptase for use in drug screening
Grant 6,617,110 - Cech , et al. September 9, 2
2003-09-09
Human telomerase catalytic subunit: diagnostic and therapeutic methods
App 20030100093 - Cech, Thomas R. ;   et al.
2003-05-29
Human telomerase catalytic subunit: diagnostic and therapeutic methods
App 20030096344 - Cech, Thomas R. ;   et al.
2003-05-22
Novel telomerase
App 20030059787 - Cech, Thomas R. ;   et al.
2003-03-27
Novel telomerase
App 20030044953 - Cech, Thomas R. ;   et al.
2003-03-06
Novel telomerase
App 20030032075 - Cech, Thomas R. ;   et al.
2003-02-13
Novel Telomerase
App 20030009019 - CECH, THOMAS R. ;   et al.
2003-01-09
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
App 20020173476 - Cech, Thomas R. ;   et al.
2002-11-21
Novel telomerase
App 20020164786 - Cech, Thomas R. ;   et al.
2002-11-07
Human telomerase catalytic subunit: diagnostic and therapeutic methods
Grant 6,475,789 - Cech , et al. November 5, 2
2002-11-05
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
Grant 6,444,650 - Cech , et al. September 3, 2
2002-09-03
Telomerase
Grant 6,261,836 - Cech , et al. July 17, 2
2001-07-17
Methods of screening for compounds that derepress or increase telomerase activity
Grant 6,007,989 - West , et al. December 28, 1
1999-12-28
Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
Grant 5,645,986 - West , et al. July 8, 1
1997-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed